Sierra Leone vs Tanzania, United Republic of: Access to anti-retroviral drugs, male
Sierra Leone
82.0%
in 2024
Tanzania, United Republic of
83.0%
in 2024
Sierra Leone rank
42nd
Tanzania, United Republic of rank
40th
Access to anti-retroviral drugs, male over time
- Sierra Leone
- Tanzania, United Republic of
How they compare
Tanzania, United Republic of currently reports 83.0% against 82.0% in Sierra Leone, a difference of 1.0%.
Across all 25 years both countries report, Tanzania, United Republic of has been ahead every year.
Sierra Leone ranks 42nd and Tanzania, United Republic of ranks 40th of 141 countries.
Tanzania, United Republic of has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sierra Leone | Tanzania, United Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.5% | 5.5% | 4.0% | Tanzania, United Republic of |
| 2010s | 16.7% | 34.9% | 18.2% | Tanzania, United Republic of |
| 2020s | 56.8% | 72.8% | 16.0% | Tanzania, United Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Sierra Leone or Tanzania, United Republic of?
- Tanzania, United Republic of, at 83.0% against 82.0% in Sierra Leone as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Sierra Leone and Tanzania, United Republic of?
- 1.0%, with Tanzania, United Republic of ahead.
- How many years of comparable data are there for Sierra Leone and Tanzania, United Republic of?
- 25 years are reported by both, from 2000 to 2024.
- How do Sierra Leone and Tanzania, United Republic of rank globally for access to anti-retroviral drugs, male?
- Sierra Leone ranks 42nd and Tanzania, United Republic of ranks 40th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.